Atlas FDA

Senographe Pristina 3D and SenoClaire

FDA premarket approval P130020/S004 · decided 2021-03-23

Approval details

PMA number
P130020
Supplement
S004
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Senographe Pristina 3D and SenoClaire
Generic name
Digital breast tomosynthesis
Applicant
GE Healthcare
Date received
2020-05-04
Decision date
2021-03-23
Days to decision
323 days
Decision code
APPR
Product code
OTE
Advisory committee
Radiology
Expedited review
No
Location
Waukesha, WI
Statement
Approval of the algorithm updates of the Synthetized 2D image called V-Preview for the Senographe Pristina 3D and SenoClaire.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
View (K253639)GE Healthcare2026-01-08
MR Contour DL (K242925)GE Healthcare2025-04-01
Digital Expert Access with Remote Scanning (K232346)GE Healthcare2023-10-27
Precision DL (K223212)GE Healthcare2023-04-27
Xeleris V Processing and Review System (K221680)GE Healthcare2023-03-01
Omni Legend (K221932)GE Healthcare2022-09-02
Voluson P6, Voluson P8 (K213689)GE Healthcare2022-02-17
Voluson S6, Voluson S8, Voluson S8t, Voluson S10, Voluson S10 Expert (K213642)GE Healthcare2022-01-13